Metronidazole USP from Canada
Metronidazole is a synthetic nitroimidazole derivative classified as a drug under HTS 2933.29.4500 due to its unfused imidazole ring structure and primary use as an antibiotic. It treats anaerobic bacterial infections, protozoal infections like trichomoniasis, and certain gastrointestinal conditions.
Duty Rate — Canada → United States
3.7%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Obtain FDA Drug Master File (DMF) and ensure compliance with USP standards for purity and impurities
• Provide Certificate of Analysis (CoA) and stability data; common pitfall is inadequate microbial testing documentation
• Verify bulk API status vs finished dosage forms to avoid misclassification under Chapter 30